326 related articles for article (PubMed ID: 34899577)
1. A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.
Boziki M; Styliadis C; Bakirtzis C; Grigoriadou E; Sintila AS; Nikolaidis I; Vrienniou A; Geys L; Pelidou SH; Probert L; Papazisis G; Bamidis P; Grigoriadis N
Front Neurol; 2021; 12():757038. PubMed ID: 34899577
[No Abstract] [Full Text] [Related]
2. Vaccine hesitancy among people with multiple sclerosis.
Yap SM; Al Hinai M; Gaughan M; Callanan I; Kearney H; Tubridy N; McGuigan C
Mult Scler Relat Disord; 2021 Nov; 56():103236. PubMed ID: 34507240
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccination Reactogenicity in Persons With Multiple Sclerosis.
Briggs FBS; Mateen FJ; Schmidt H; Currie KM; Siefers HM; Crouthamel S; Bebo BF; Fiol J; Racke MK; O'Connor KC; Kolaczkowski LG; Klein P; Loud S; McBurney RN
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34753828
[TBL] [Abstract][Full Text] [Related]
4. Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.
Vogel AC; Schmidt H; Loud S; McBurney R; Mateen FJ
Mult Scler Relat Disord; 2020 Nov; 46():102512. PubMed ID: 32977074
[TBL] [Abstract][Full Text] [Related]
5. Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.
Meltzer E; Charron O; Wozny J; Onuorah H; Montague A; Kline AC; Largent A; Krause TM; Freeman L
Mult Scler Relat Disord; 2023 Dec; 80():105085. PubMed ID: 37931487
[TBL] [Abstract][Full Text] [Related]
6. Frequency and characteristics of falls in people living with and without multiple sclerosis during the COVID-19 pandemic: A cross-sectional online survey.
Zanotto T; Frechette ML; Koziel SR; Hsieh KL; Sosnoff JJ
Mult Scler Relat Disord; 2021 Sep; 54():103111. PubMed ID: 34303279
[TBL] [Abstract][Full Text] [Related]
7. A year with the fear of COVID-19 in multiple sclerosis patients: Examination of depression, sleep quality and quality of life before and after the pandemic.
Yeni K; Tulek Z; Terzi M
Mult Scler Relat Disord; 2022 Jan; 57():103370. PubMed ID: 35158434
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis and COVID-19: a northern China survey.
Guo Q; Wang T; Huang Y; Wang F; Hao P; Fang L
Neurol Sci; 2024 May; ():. PubMed ID: 38722503
[TBL] [Abstract][Full Text] [Related]
9. Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey.
Huang Y; Rodgers WJ; Middleton RM; Baheerathan A; Tuite-Dalton KA; Ford DV; Nicholas R; Group MRR
Mult Scler Relat Disord; 2021 Oct; 55():103175. PubMed ID: 34343866
[TBL] [Abstract][Full Text] [Related]
10. Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine.
Moniz Dionísio J; Santos M; Rodrigues AM; Rêgo A; Vítor J; Delgado S; Pinheiro R; Neves P; Figueiredo C; Costa JB; Vale J; Salgado V; Timóteo Â
Mult Scler Relat Disord; 2021 Sep; 54():103113. PubMed ID: 34216996
[TBL] [Abstract][Full Text] [Related]
11. The Psychological Impact of COVID-19 Pandemic on People With Multiple Sclerosis.
Motolese F; Rossi M; Albergo G; Stelitano D; Villanova M; Di Lazzaro V; Capone F
Front Neurol; 2020; 11():580507. PubMed ID: 33193033
[No Abstract] [Full Text] [Related]
12. Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations.
Pugliatti M; Berger T; Hartung HP; Oreja-Guevara C; Bar-Or A
Curr Opin Neurol; 2022 Jun; 35(3):319-327. PubMed ID: 35674075
[TBL] [Abstract][Full Text] [Related]
13. Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States.
Ehde DM; Roberts MK; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Apr; 49():102788. PubMed ID: 33508570
[TBL] [Abstract][Full Text] [Related]
14. Experiences of persons with multiple sclerosis with the Covid-19 vaccination: A cross-sectional study of the Swiss Multiple Sclerosis Registry.
Stanikić M; Twomey E; Puhan MA; Kamm CP; Salmen A; Ajdacic-Gross V; Zecca C; Gobbi C; von Wyl V;
Mult Scler Relat Disord; 2023 Jun; 74():104707. PubMed ID: 37068368
[TBL] [Abstract][Full Text] [Related]
15. A Targeted Literature Search and Phenomenological Review of Perspectives of People with Multiple Sclerosis and Healthcare Professionals of the Immunology of Disease-Modifying Therapies.
Burtchell J; Clemmons D; Clemmons J; Sabutis T; Rosenberg A; Graves J; Sweeney ML; Kramer J; Ziehn M; Brown B; Weiss JL; Obeidat AZ
Neurol Ther; 2022 Sep; 11(3):955-979. PubMed ID: 35608740
[TBL] [Abstract][Full Text] [Related]
16. Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis.
Allen-Philbey K; Stennett A; Begum T; Johnson AC; MacDougall A; Green S; Dobson R; Giovannoni G; Gnanapavan S; Marta M; Smets I; Turner BP; Baker D; Mathews J; Schmierer K
Mult Scler Relat Disord; 2022 Sep; 65():104022. PubMed ID: 35816953
[TBL] [Abstract][Full Text] [Related]
17. Impact of vaccination on COVID-19 outcome in multiple sclerosis.
Bsteh G; Gradl C; Heschl B; Hegen H; Di Pauli F; Assar H; Leutmezer F; Traxler G; Krajnc N; Zulehner G; Hiller MS; Rommer P; Wipfler P; Guger M; Enzinger C; Berger T;
Eur J Neurol; 2022 Jul; ():. PubMed ID: 35791496
[TBL] [Abstract][Full Text] [Related]
18. Perceived stress and social support in a large population of people with multiple sclerosis recruited online through the COVID-19 pandemic.
Bonavita S; Sparaco M; Russo A; Borriello G; Lavorgna L
Eur J Neurol; 2021 Oct; 28(10):3396-3402. PubMed ID: 33368849
[TBL] [Abstract][Full Text] [Related]
19. Safety of disease-modifying treatments in SARS-CoV-2 antibody-positive multiple sclerosis patients.
Mallucci G; Zito A; Baldanti F; Gastaldi M; Fabbro BD; Franciotta D; Bergamaschi R
Mult Scler Relat Disord; 2021 Apr; 49():102754. PubMed ID: 33609958
[TBL] [Abstract][Full Text] [Related]
20. Vaccination Setting of Patients with Autoimmune Diseases in Times of Severe Acute Respiratory Syndrome Coronavirus Type 2 Pandemic Using the Example of Multiple Sclerosis Patients: A Longitudinal Multicenter Study.
Heidler F; Baldt J; Frahm N; Langhorst SE; Mashhadiakbar P; Streckenbach B; Zettl UK; Richter J
Eur Neurol; 2022; 85(2):104-111. PubMed ID: 34743082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
